calendar

4 catalysts · 4 approval

next 91 dayslessmore

MonWedFri

view

sort

type

therapy area

no tagged catalysts yet

Week of Jan 18, 2016

›Jan 19, 2016approval3857d agoKESIMPTA (OFATUMUMAB) — FDA approvalKESIMPTA

Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

›Jan 19, 2016approval3857d agoVIVITROL (NALTREXONE) — FDA approvalnaltrexone ER

Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

›Jan 19, 2016approval3857d agoQOLIANA (BRIMONIDINE TARTRATE) — FDA approvalLumify

Sponsor: SANDOZ. Form: SOLUTION/DROPS. Route: OPHTHALMIC

›Jan 19, 2016approval3857d agoLACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

$NVS156.33+1.37%

$ALKS48.84-0.67%